After a solid 2.4x rise from its March 2020 lows, at the current price of $31 per share, Bausch Health Companies' stock, best known for its contact lenses and branded generic drugs, appears to be fully valued. BHC stock has rallied from $13 to $31 off the March 2020 bottom compared to the S&P...
Should You Book Profits In Bausch Health Companies Stock After A Solid 2x Rally?
Forbes - 26 Feb 2021 17:20
After a solid 2.4x rise from its March 2020 lows, at the current price of $31 per share, Bausch Health Companies' stock, best known for its contact lenses and branded generic drugs, appears to be fully valued. BHC stock has rallied from $13 to $31 off the March 2020 bottom compared to the S&P...
Share this Article
Recommended